Results

Total Results: 2,228 records

Showing results for "disease".

  1. 04-E029-1 Summary (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
    December 01, 2011 - Incidence of metastatic disease d. Quality of life e. Costs 5. … No more than 20 percent of the study sample could exhibit more advanced disease. … We also extracted definitions of disease progression. … additional basic and clinical research is needed to more accurately classify or predict those men whose diseases … No trial provided results from comparisons of AS with RP or RT in men with localized diseases.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
    June 01, 2012 - Spectrum effect The severity or type of disease may affect test accuracy. … Secular trends in population risk and disease prevalence Prevalence is tied to disease definitions that … A simple change in definition can have a great impact on disease prevalence. … be diagnosed and have the course of their disease altered. … Has the treatment of the related disease improved or changed?
  3. effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
    June 01, 2012 - Spectrum effect The severity or type of disease may affect test accuracy. … Secular trends in population risk and disease prevalence Prevalence is tied to disease definitions that … A simple change in definition can have a great impact on disease prevalence. … be diagnosed and have the course of their disease altered. … Has the treatment of the related disease improved or changed?
  4. S123 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
    October 01, 2007 - In addition, patients with more severe disease are assumed to have lower survival odds regardless of … severity, this leads to the following surgery choice model as a function of disease severity: S � c0 … If the survival risk of BCSI is thought to increase with L (b1 � 0), the patients with higher disease … and disease severity in- creases (eg, larger vs. smaller tumor size) as we move to the right on the … In this case, ESBC patients with the lowest disease severity and those with the highest disease severity
  5. effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
    January 01, 2012 - Horizon Scanning System – Potential High Impact Interventions Report Priority Area 13: Pulmonary Disease … ES-2 Pulmonary Disease, Including Asthma, Interventions ........................................... … Priority Area 13: Pulmonary Disease, Including Asthma Topic High Impact Potential 1. … Roflumilast (Daliresp) for treatment of chronic obstructive pulmonary disease No high-impact potential … The primary treatment goal is to lessen symptoms and slow disease progression.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - England Journal of Medicine), as well as these specialty journals: Rheumatology, Annals of Rheumatic Diseases … oral   DMARD:  Mixed results for disease activity. … Legend: ACR: American College of Rheumatology; DAS: Disease Activity Score; DMARD: Disease-modifying … factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases … MEDICINE BMJ JAMA LANCET NEW ENGLAND JOURNAL OF MEDICINE ANNALS OF THE RHEUMATIC DISEASES
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - England Journal of Medicine), as well as these specialty journals: Rheumatology, Annals of Rheumatic Diseases … oral   DMARD:  Mixed results for disease activity. … Legend: ACR: American College of Rheumatology; DAS: Disease Activity Score; DMARD: Disease-modifying … factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases … MEDICINE BMJ JAMA LANCET NEW ENGLAND JOURNAL OF MEDICINE ANNALS OF THE RHEUMATIC DISEASES
  8. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
    January 01, 2007 - Peripheral vascular disease. … morbidity, microvascular disease, and peripheral vascular disease. … lactic acidosis would help determine the safety of using this medication in populations with comorbid diseases … , congestive heart failure, liver disease, or psychiatric disease. … medications in effects on peripheral vascular disease. 2e.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-outcomes_methods.pdf
    July 01, 2012 - screening for reportable diseases such as syphilis or HIV. … Numerous clinical management effects might follow testing for coronary artery disease with CT. … An individual diagnosed with coronary disease might alter his or her lifestyle to reduce disease progression … Although the prognoses for some diseases are minimally modifiable with current treatments, most prognostic … Principles and practice of mass screening for disease. WHO Chronicle 1968;22:473. 8.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_executive.pdf
    January 01, 2013 - Disease-Specific Health Outcomes The effect of CM on disease-specific outcomes was inconsistent. … Older adults with one or more chronic diseases Mortality. … Older adults with one or more chronic diseases Disease burden. … Older adults with one or more chronic diseases Personal contact. … A taxonomy for disease management: a scientific statement from the American Heart Association Disease
  11. effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - higher risk disease. … Who dies of http://www.effectivehealthcare.ahrq.gov/reports/final.cfm 20 disease? … progression 36 months No statistically significant disease progression. … higher risk disease. … Do Not Know subjects with T2c disease but not in T2b subjects.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - higher risk disease. … Who dies of http://www.effectivehealthcare.ahrq.gov/reports/final.cfm 20 disease? … progression 36 months No statistically significant disease progression. … higher risk disease. … Do Not Know subjects with T2c disease but not in T2b subjects.
  13. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
    January 01, 2012 - (The therapy has also recently been identified as being explored for other autoimmune diseases such … The rationale for this treatment stems from the fact that inflammatory bowel diseases are rare in developing … The rationale for this treatment stems from the fact that inflammatory bowel diseases are rare in developing … and other inflammatory bowel diseases. 8 It does not appear that the manufacturer intends to … Bethesda (MD): National Digestive Diseases Information Clearinghouse; [accessed 2011 Jun 6]. [4 p
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
    March 01, 2016 - , chronic kidney disease, bone disease, hyperlipidemia, cancer, depression, and neurocognitive impairment … This may lead to delayed diagnosis and greater disease burden for the individual. … Clinical infectious diseases : an official publication of the Infectious Diseases Society of America … HIV infection and cardiovascular disease. European heart journal. 2014;35(21):1373-1381. 12. … Psychological symptoms among persons 50 years of age and older living with HIV disease.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
    January 01, 2011 - were determined to have diabetes if they had two or more claims with International Classification of Diseases … The former set of ICD-9 codes represents the following macrovascular diseases: peripheral arterial … disease, myocardial infarction, heart failure, angina, and cere- brovascular disease. … The latter set of ICD-9 codes represents the following microvascular diseases: diabetic renal disease … , diabetic ophthalmic disease, and diabetic neurologic disease.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
    August 01, 2012 - – Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … – Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … – Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … • Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease … Ischemic heart disease in women: facts and wishful thinking.
  17. effectivehealthcare.ahrq.gov/sites/default/files/searching.ppt
    January 01, 2011 - Searches would include the disease, intervention, and terms for RCTs. … However, it is also sufficient to include the intervention, harms, and the disease of interest. … Arterial occlusive disease/ Peripheral vascular diseases/ Vascular diseases/ Atherosclerosis/ Cardiovascular … diseases/ Carotid artery diseases/ (((preserved adj left) or (stable adj cad) or (stable adj chd) or … adj lvef) or (normal adj ef)).mp 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 Terms for vascular diseases
  18. Introduction (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-1_research.pdf
    February 01, 2009 - rheumatoid arthritis, disease modifying anti-rheumatic drugs, epidemiology Effective Health Care … Research Report Number 8 Introduction The treatment of rheumatoid arthritis (RA) with disease modifying … anti-rheumatic drugs (DMARDs) provides control of disease activity, slows joint erosions and improves … remission after 3 years.9,10 The lack of information on disease duration or disease activity measurements … The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis
  19. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
    April 01, 2012 - Horizon Scanning System – Potential High Impact Interventions Report Priority Area 13: Pulmonary Disease … ES-2 Pulmonary Disease, Including Asthma, Interventions ........................................... … ES-2 AHRQ Healthcare Horizon Scanning System AHRQ Priority Area 13 – Pulmonary Disease … Priority Area 13: Pulmonary Disease (including Asthma) 1. … Roflumilast (Daliresp) for treatment of chronic obstructive pulmonary disease Discussion Pulmonary
  20. effectivehealthcare.ahrq.gov/sites/default/files/branson-text.pdf
    October 13, 2011 - providers Slide 4 Characteristics of Patient Representatives § Have personal experience with the disease … § Are knowledgeable about treatment options and/or the science of the disease § Are able to be objective … groups may offer an opportunity to identify patients who might be underrepresented (such as for rare diseases … Advocacy experience § Ability to represent other patients/survivors § Knowledge and skills related to disease … area § Alternate disease experience § Work experience § Education § Interview representatives.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: